10'-( .omega.-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenoth

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3154

Patent

active

040839761

ABSTRACT:
Novel compounds 10'-[.omega.-N/1,4-diazabicyclo(4,m,0)-alkanyl/-acyl] -phenothiazines having the formula: ##STR1## wherein X = H, Cl, CF.sub.3 ; n = 1, 2, 3; m = 3, 5; and their salts of acidic addition and quaternary salts. The process for producing said compounds comprises reacting .omega. -chloracyl -2-substituted phenothiazines with 1,4-diazabicyclo(4,m,0)-alkanes in an inert solvent medium at a temperature of 50-140.degree. C followed by isolation of the desired product.
Said compounds are pharmacologically active. The most active compound 10'- [.beta.-N-/1,4-diazabicyclo-(4,3,0)-nonanyl/-propyonyl]-2'-chlorophenothia zine of the formula: ##STR2## is an active principle of a medicated compound possessing spasmolytic and coronary-dilatant effect.

REFERENCES:
patent: 2591679 (1952-04-01), Cusic
patent: 2694705 (1954-11-01), Cusic
patent: 3055891 (1962-09-01), Cusic
patent: 3320246 (1967-05-01), Cusic et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

10'-( .omega.-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenoth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 10'-( .omega.-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenoth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 10'-( .omega.-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenoth will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-989733

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.